MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

Search

Merit Medical Systems Inc

Aperta

SettoreSettore sanitario

83.91 0.88

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

81.99

Massimo

84.5

Metriche Chiave

By Trading Economics

Entrata

-4.8M

28M

Vendite

1.7M

384M

P/E

Media del settore

42.21

89.037

Margine di Profitto

7.225

Dipendenti

7,400

EBITDA

-4.4M

80M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+28.68% upside

Dividendi

By Dow Jones

Utili prossimi

24 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-20M

4.9B

Apertura precedente

83.03

Chiusura precedente

83.91

Notizie sul Sentiment di mercato

By Acuity

50%

50%

177 / 360 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Merit Medical Systems Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 gen 2026, 23:49 UTC

I principali Market Mover

Karman Space & Defense Shares Rise as 2026 Forecast Tops Analyst Estimates

21 gen 2026, 21:12 UTC

I principali Market Mover

Automaker Stocks Rise After Trump Calls Off European Tariffs

21 gen 2026, 21:00 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Borse Group to Acquire Allfunds for $6.19 Billion

21 gen 2026, 20:29 UTC

I principali Market Mover

Chip Makers Gain After Trump Calls Off European Tariffs

21 gen 2026, 20:04 UTC

I principali Market Mover

Apparel, Footwear Stocks Rise After Trump Calls Off European Tariffs

21 gen 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise as U.S.-Europe Tensions Ease -- Market Talk

21 gen 2026, 23:34 UTC

Discorsi di Mercato

Gold Falls Amid Easing U.S.-Europe Tensions Over Greenland -- Market Talk

21 gen 2026, 22:39 UTC

Utili

Schwab's Profit Jumps on Surge in Brokerage Activity -- 2nd Update

21 gen 2026, 21:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

21 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

21 gen 2026, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Tesla Stock In Focus as Musk and Ryanair Chief Trade Insults. Should Investors Worry? -- Barrons.com

21 gen 2026, 21:19 UTC

Utili

Charles Schwab Earnings Miss Estimates. The Stock Is Rising Anyway. -- Barrons.com

21 gen 2026, 20:45 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Borse Group to Acquire Allfunds for $6.19B

21 gen 2026, 20:36 UTC

Discorsi di Mercato

U.S. Natural Gas Posts Back-to-Back Hefty Gains -- Market Talk

21 gen 2026, 20:31 UTC

Discorsi di Mercato

Oil Settles Higher With Support From Heating Fuel -- Market Talk

21 gen 2026, 20:27 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse Expects Combined Company Will Be Able to Achieve Annual Run Rate Pretax Cost Synergies of About EUR60M

21 gen 2026, 20:27 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

21 gen 2026, 20:27 UTC

Discorsi di Mercato

Was It a 'TACO' Event? -- Market Talk

21 gen 2026, 20:26 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse Has Received Irrevocable Undertakings in Support of Acquisition in Respect of About 48.9% of Allfunds Issued Share Capital Excluding Treasury Shares

21 gen 2026, 20:23 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse: Allfunds Stockholders to Receive EUR8.80/Shr, Including Cash, Stock and Permitted Dividend

21 gen 2026, 20:21 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse: Agreement Values Allfunds at About EUR5.3B

21 gen 2026, 20:19 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse Group Agrees to Buy Allfunds

21 gen 2026, 20:08 UTC

Utili

Prologis Revenue Climbs as Warehouse Demand Rebounds -- Update

21 gen 2026, 20:03 UTC

Discorsi di Mercato

Precious Metals Drop After Trump Posts About Greenland Deal -- Market Talk

21 gen 2026, 19:51 UTC

Discorsi di Mercato

Treasury Markets React to Trump's Softer Tone About Greenland -- Market Talk

21 gen 2026, 19:43 UTC

Discorsi di Mercato

U.S. Ethanol Production Expected to Slip -- Market Talk

21 gen 2026, 19:31 UTC

Discorsi di Mercato

Gold Settles at Fresh All-Time High -- Market Talk

21 gen 2026, 19:24 UTC

Utili

Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls. -- Barrons.com

21 gen 2026, 19:10 UTC

Discorsi di Mercato

Mexican Inflation Seen Picking Up in Early January -- Market Talk

21 gen 2026, 18:57 UTC

Discorsi di Mercato

DAVOS: IBM CEO Krishna Says World Is More Volatile Now -- Market Talk

Confronto tra pari

Modifica del prezzo

Merit Medical Systems Inc Previsione

Obiettivo di Prezzo

By TipRanks

28.68% in crescita

Previsioni per 12 mesi

Media 105.13 USD  28.68%

Alto 122 USD

Basso 90 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Merit Medical Systems Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

7

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

95.585 / 96.35Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

177 / 360 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat